Overview
- Rocket Lab filed a sales agreement to sell up to $750 million of common stock over time through multiple agents, with no obligation to sell a set amount.
- The new program replaces a March agreement after the company sold $396.6 million under a prior $500 million authorization, which it now plans to terminate.
- The stock fell as much as about 12% on Tuesday to the $47–$48 range and edged higher on Wednesday in early trading.
- Rocket Lab reported approximately $564.08 million in cash and cash equivalents as of June 30, according to recent disclosures.
- Management frames the raise as funding for growth initiatives such as the larger Neutron rocket and a proposed Mars Telecommunications Orbiter, while sell‑side ratings remain positive and independent analysis flags potential 20–30% further downside to around $33.